An amended in vitro-in vivo extrapolation model that accounts for first pass clearance effects on chemical bioaccumulation in fish

被引:0
|
作者
Saunders, Leslie J. [1 ]
Nichols, John W. [2 ]
Arnot, Jon A. [1 ,3 ]
Armitage, James M. [4 ]
Wania, Frank [1 ]
机构
[1] Univ Toronto Scarborough, Dept Phys & Environm Sci, Toronto, ON, Canada
[2] US Environm Protect Agcy, Duluth, MN USA
[3] ARC Arnot Res & Consulting, Toronto, ON, Canada
[4] AES Armitage Environm Sci Inc, Ottawa, ON, Canada
关键词
TROUT ONCORHYNCHUS-MYKISS; FRESHLY ISOLATED HEPATOCYTES; METABOLIC BIOTRANSFORMATION RATES; XENOBIOTIC INTRINSIC CLEARANCE; HYDROPHOBIC ORGANIC-CHEMICALS; BLOOD-FLOW; GASTROINTESTINAL-TRACT; BIOCONCENTRATION; BIOMAGNIFICATION; ELIMINATION;
D O I
10.1039/d2em00522k
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Measured rates of in vitro intrinsic clearance for fish may be extrapolated to the whole animal as a means of estimating a whole-body biotransformation rate constant (k(B); d(-1)). This estimate of k(B) can then be used as an input to existing bioaccumulation prediction models. Most in vitro-in vivo extrapolation/bioaccumulation (IVIVE/B) modeling efforts to date have focused on predicting the chemical bioconcentration in fish (aqueous only exposure), with less attention paid to dietary exposures. Following dietary uptake, biotransformation in the gut lumen, intestinal epithelia, and liver can reduce chemical accumulation; however, current IVIVE/B models do not consider these first pass clearance effects on dietary uptake. Here we present an amended IVIVE/B model that accounts for first pass clearance. The model is then used to examine how biotransformation in the liver and intestinal epithelia (alone or combined) may impact chemical accumulation that occurs during dietary exposure. First pass clearance by the liver can greatly reduce dietary uptake of contaminants, but these effects are only apparent at rapid rates of in vitro biotransformation (first order depletion rate constant k(DEP) >= 10 h(-1)). The impact of first pass clearance becomes more pronounced when biotransformation in the intestinal epithelia is included in the model. Modelled results suggest that biotransformation in the liver and intestinal epithelia cannot entirely explain reduced dietary uptake reported in several in vivo bioaccumulation tests. This unexplained reduction in dietary uptake is attributed to chemical degradation in the gut lumen. These findings underscore the need for research to directly investigate luminal biotransformation in fish.
引用
收藏
页码:741 / 754
页数:14
相关论文
共 50 条
  • [21] In vitro-in vivo extrapolation (IVIVE) for predicting human intestinal absorption and first-pass elimination of drugs: principles and applications
    Cho, Hyun-Jong
    Kim, Ji-Eon
    Kim, Dae-Duk
    Yoon, In-Soo
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2014, 40 (08) : 989 - 998
  • [22] In vitro-in vivo extrapolation of quantitative hepatic biotransformation data for fish - I. A review of methods, and strategies for incorporating intrinsic clearance estimates into chemical kinetic models
    Nichols, John W.
    Schultz, Irvin R.
    Fitzsimmons, Patrick N.
    AQUATIC TOXICOLOGY, 2006, 78 (01) : 74 - 90
  • [23] In Vitro-In Vivo Extrapolation and Scaling Factors for Clearance of Human and Preclinical Species with Liver Microsomes and Hepatocytes
    Tess, David C.
    Chang, George
    Keefer, Christopher
    Carlo, Anthony
    Jones, Rhys
    Di, Li
    AAPS JOURNAL, 2023, 25 (03):
  • [24] The Comparison of Machine Learning and Mechanistic In Vitro-In Vivo Extrapolation Models for the Prediction of Human Intrinsic Clearance
    Keefer, Christopher E.
    Chang, George
    Di, Li
    Woody, Nathaniel A.
    Tess, David A.
    Osgood, Sarah M.
    Kapinos, Brendon
    Racich, Jill
    Carlo, Anthony A.
    Balesano, Amanda
    Ferguson, Nicholas
    Orozco, Christine
    Zueva, Larisa
    Luo, Lina
    MOLECULAR PHARMACEUTICS, 2023, 20 (11) : 5616 - 5630
  • [25] Hepatic Clearance Predictions from In Vitro-In Vivo Extrapolation and the Biopharmaceutics Drug Disposition Classification System
    Bowman, Christine M.
    Benet, Leslie Z.
    DRUG METABOLISM AND DISPOSITION, 2016, 44 (11) : 1731 - 1735
  • [26] Comparative assessment of In Vitro-In Vivo extrapolation methods used for predicting hepatic metabolic clearance of drugs
    Poulin, Patrick
    Hop, Cornelis E. C. A.
    Ho, Quynh
    Halladay, Jason S.
    Haddad, Sami
    Kenny, Jane R.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (11) : 4308 - 4326
  • [27] Population in vitro-in vivo pharmacokinetic model of first-pass metabolism: itraconazole and hydroxy-itraconazole
    Abuhelwa, Ahmad Y.
    Mudge, Stuart
    Upton, Richard N.
    Foster, David J. R.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 (02) : 181 - 197
  • [28] Toward a New Paradigm for the Efficient In Vitro-In Vivo Extrapolation of Metabolic Clearance in Humans from Hepatocyte Data
    Poulin, Patrick
    Haddad, Sami
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (09) : 3239 - 3251
  • [29] In vitro-in vivo extrapolation of hepatic clearance: using virtual experiments to identify a plausibly influential source of inaccuracies
    Hunt, C. Anthony
    Smith, Andrew K.
    Ropella, Glen E. P.
    Kennedy, Ryan C.
    FASEB JOURNAL, 2019, 33
  • [30] Evaluating Lean Liver Volume as a Potential Scaler for In Vitro-In Vivo Extrapolation of Drug Clearance in Obesity Using the Model Drug Antipyrine
    Sinha, Jaydeep
    Duffull, Stephen B.
    Green, Bruce
    Al-Sallami, Hesham S.
    CURRENT DRUG METABOLISM, 2020, 21 (10) : 746 - 750